The role of the NHRA is to regulate the provision of healthcare in Bahrain. The Economic Vision 2030 provided a clear direction for the continued development of the Kingdom’s economy and pointed to the need for the regulation of the whole healthcare system by an independent health regulator.

As a result, Bahrain has followed the example of many developed countries by separating out the regulation of health services from the provision of health services. Such separation enhances the integrity of the regulator and provides greater assurance against potential conflicts of interest. As a consequence of this change, the regulatory functions that were previously carried out by the Ministry of Health, the Kingdom’s major provider of health services, were transferred to the NHRA.

The law which establishes the NHRA was passed in 2009 and the NHRA is now charged with regulating health service provision across both the public and private sectors in Bahrain by regulating healthcare professionals, facilities where health care services are provided (hospitals, clinics, centres, pharmacies, etc.) and the medicines and drugs that are used in the delivery of healthcare. Bahrain is unique in the world, in that it brings together in the regulation of these three areas in a single regulatory authority.

Healthcare Professionals Regulation

The NHRA isresponsible for the regulation of all licensed healthcare professionals in Bahrain (covering doctors, nurses, dentists, pharmacists and allied health professionals). Professional regulation includes standard-setting, licensing, licensing examinations and managing complaints.

Healthcare Facilities Regulation

The NHRAis responsible for the regulation of all licensed healthcare facilities in Bahrain such as, hospitals, clinics, centres and pharmacies in both the public and private sectors. Facilities regulation includes standard-setting, licensing of facilities, monitoring of compliance with standards through regular inspection and managing complaints.

Medicines and Drugs Regulation

The NHRAis responsible for the regulation and control of all medicines and drugs in Bahrain. Its remit includes standard-setting, licensing, quality assurance, post-marketing surveillance and complianceand pharmacovigilence.


The NHRA also receives and handles complaints from any source concerning healthcare professionals, healthcare facilities or medicines and may pursue complaints which are of a regulatory nature. If complaints are received which are not of a regulatory nature, the complaint is passed back to the complainant with an explanation and general advice as to where the complaint might better be directed.

NHRA e-Service Zone


NHRA Newsletter
NHRA Newsletter 5
September, 2018
NHRA Media Center
Photo Gallery